Major Hepatectomy for Hilar Cholangiocarcinoma Type 3 and 4: Prognostic Factors and Longterm Outcomes
- 28 February 2007
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 204 (2) , 250-260
- https://doi.org/10.1016/j.jamcollsurg.2006.10.028
Abstract
Radical operation for hilar cholangiocarcinoma, including major hepatectomy with vascular resection, seems to improve longterm survival. This study retrospectively evaluates several prognostic risk factors that can influence survival after resection of types 3 to 4 Klatskin tumors. Between 1984 and 2003, 59 patients (36 men and 23 women) with types 3 to 4 hilar cholangiocarcinoma underwent liver resection with curative intent. Medical records and pathologic findings were reviewed to assess prognostic risk factors and survival. Disease-free and overall survival were analyzed using Kaplan-Meier and Cox proportional hazards models. Survival rates at 1, 3, and 5 years were 82%, 45%, and 20% respectively. In-hospital mortality was 5% and morbidity was 42%. In multivariable analysis, male gender (relative risk [RR] = 5.4; 95% CI, 2.2 to 13.5), absence of preoperative chemotherapy (RR = 4; 95% CI, 1.5 to 10.7), R1 biliary tract margin (RR = 2.6; 95% CI, 1.1 to 4.4), and metastatic celiac lymph nodes (RR = 19.9; 95% CI, 4 to 71.4) were found to be independent factors for overall survival. Pedicular metastatic lymph nodes were not associated with poorer overall survival. If biliary positive-margin is the only risk factor, the 5-year estimated overall survival is 70%. Major hepatectomy can improve outcomes of hilar cholangiocarcinoma. Compared with nonoperative treatment or R0 hepatectomy, R1 resection in patients with no other risk factor can offer longterm survival.Keywords
This publication has 31 references indexed in Scilit:
- Hepatectomy With Portal Vein Resection for Hilar CholangiocarcinomaAnnals of Surgery, 2003
- Results of Surgical Resection for Patients With Hilar Bile Duct CancerAnnals of Surgery, 2003
- Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinomaCancer, 2003
- Liver transplantation for cholangiocellular carcinoma: Analysis of a single-center experience and review of the literatureLiver Transplantation, 2001
- Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured LiverAnnals of Surgery, 2000
- One hundred and eleven liver resections for hilar bile duct cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapyBritish Journal of Surgery, 1995
- Changing trends in the management of extrahepatic cholangiocarcinomaBritish Journal of Surgery, 1993
- Combined portal vein and liver resection for carcinoma of the biliary tractBritish Journal of Surgery, 1991
- Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatisThe American Journal of Medicine, 1965